| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YRTPH.2014.04.016 |
| P698 | PubMed publication ID | 24819671 |
| P2093 | author name string | Akira Kikuchi | |
| Chikako Sakaguchi | |||
| Naoki Minami | |||
| Aoi Kakehi | |||
| Yasuyuki Futamura | |||
| P2860 | cites work | The intractable cigarette 'filter problem' | Q33877096 |
| Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine | Q35046473 | ||
| Biomonitoring of inhaled complex mixtures--ambient air, diesel exhaust and cigarette smoke | Q36224667 | ||
| Existing technologies to reduce specific toxicant emissions in cigarette smoke | Q37259825 | ||
| Comparative studies on the genotoxic activity of mainstream smoke condensate from cigarettes which burn or only heat tobacco | Q41748579 | ||
| Short-term exposure evaluation of adult smokers switching from conventional to first-generation electrically heated cigarettes during controlled smoking | Q45221728 | ||
| Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 2. In vitro toxicology of mainstream smoke condensate | Q50130929 | ||
| The kinetics of mutagen excretion in the urine of cigarette smokers | Q50205388 | ||
| A simple modification of the Salmonella liquid-incubation assay Increased sensitivity for detecting mutagens in human urine | Q50211268 | ||
| Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 3: Eight-day randomized clinical trial in the UK. | Q51313803 | ||
| Mainstream smoke constituent yields and predicting relationships from a worldwide market sample of cigarette brands: ISO smoking conditions. | Q51698613 | ||
| Short-term clinical exposure evaluation of a second-generation electrically heated cigarette smoking system. | Q51759214 | ||
| Estimation of mouth level exposure to smoke constituents of cigarettes with different tar levels using filter analysis. | Q53101903 | ||
| Human urine mutagenicity study comparing cigarettes which burn or only heat tobacco | Q60692599 | ||
| Ninety-day inhalation study in rats, comparing smoke from cigarettes that heat tobacco with those that burn tobacco | Q69426839 | ||
| Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 1. Chemical composition of mainstream smoke | Q74605329 | ||
| Chemical and biological studies of a new cigarette that primarily heats tobacco. Part 3. In vitro toxicity of whole smoke | Q74605334 | ||
| A safer method for the measurement of plasma thiocyanate | Q77228115 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 338-347 | |
| P577 | publication date | 2014-05-10 | |
| P1433 | published in | Regulatory Toxicology and Pharmacology | Q2138805 |
| P1476 | title | Exposure evaluation of adult male Japanese smokers switched to a heated cigarette in a controlled clinical setting | |
| P478 | volume | 69 |
| Q38613709 | A randomised, controlled, two-Centre open-label study in healthy Japanese subjects to evaluate the effect on biomarkers of exposure of switching from a conventional cigarette to a tobacco heating product |
| Q86739758 | A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product |
| Q36617575 | Acrolein inhalation alters arterial blood gases and triggers carotid body-mediated cardiovascular responses in hypertensive rats. |
| Q88605300 | Assessment of the exposure to harmful and potentially harmful constituents in healthy Japanese smokers using a novel tobacco vapor product compared with conventional cigarettes and smoking abstinence |
| Q58781917 | Carbon monoxide levels after inhalation from new generation heated tobacco products |
| Q50180986 | Chemical analysis and in vitro toxicological evaluation of aerosol from a novel tobacco vapor product: A comparison with cigarette smoke. |
| Q89230370 | Effects of Switching to the Menthol Tobacco Heating System 2.2, Smoking Abstinence, or Continued Cigarette Smoking on Clinically Relevant Risk Markers: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory |
| Q55020795 | Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings ( |
| Q50277300 | Evaluation of the Tobacco Heating System 2.2. Part 8: 5-Day randomized reduced exposure clinical study in Poland |
| Q50275831 | Evaluation of the tobacco heating system 2.2. Part 9: Application of systems pharmacology to identify exposure response markers in peripheral blood of smokers switching to THS2.2. |
| Q92268039 | Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2) |
| Q91509105 | Oxidative stress responses in human bronchial epithelial cells exposed to cigarette smoke and vapor from tobacco- and nicotine-containing products |
| Q88010564 | Pharmacokinetics of nicotine following the controlled use of a prototype novel tobacco vapor product |
| Q46234007 | Tobacco papers and tobacco industry ties in regulatory toxicology and pharmacology |
Search more.